General surgery considerations in the era of mechanical circulatory assist devices

Surg Clin North Am. 2013 Dec;93(6):1343-57. doi: 10.1016/j.suc.2013.08.004.

Abstract

Much of the success of left ventricular assist devices (LVAD) can be attributed to the second-generation HeartMate II (Thoratec, Pleasanton, CA, USA), which is the most commonly used device to date. The latest generation of LVADs is currently undergoing clinical trials worldwide. Developers have focused on improving the limitations of the second generation with emphasis on enhancing efficiency further, decreasing complications, and increasing ease of implantability. Clinical management of a patient with an LVAD is also an excellent example of the multidisciplinary approach of care that is undoubtedly the future of medicine.

Keywords: General surgery; LVAD; Left ventricular assist device; Mechanical circulatory support; Noncardiac surgery.

Publication types

  • Review

MeSH terms

  • Elective Surgical Procedures* / mortality
  • Equipment Design
  • Heart Failure / epidemiology*
  • Heart Failure / therapy
  • Heart-Assist Devices*
  • Humans
  • Patient Care Team
  • Patient Selection*
  • Risk Assessment
  • Risk Factors